Market Place
Sourcing Support
Themis Medicare posts Q1 FY25 consolidated PAT higher at Rs. 24.68 Cr
31 Jul 2024 //
INDIANPHARMAPOST
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
04 Jan 2023 //
INDIANPHARMAPOST
Themis Medicare revenue down 15.26%; Profit down 7.76%
09 Nov 2022 //
INDIANPHARMAPOST
Themis Medi bets big on antiviral drug for Covid
12 Jul 2022 //
ECONOMIC TIMES
Themis Medicare’s VIRALEX bags approval against COVID-19, viral infections
08 Jul 2022 //
ET HEALTH
Themis gets DCGI’s nod to launch Inosine Pranobex to treat Covid-19
12 Mar 2022 //
ECONOMIC TIMES
Themis Medicare`s antiviral drug, Viralex receives DCGI approval for Covid-19
09 Mar 2022 //
PHARMABIZ
Themis eyes phase 3 study for chikungunya vaccine
12 Nov 2018 //
FIERCE BIOTECH
Themis eyes phase 3 study for chikungunya vaccine
12 Nov 2018 //
FIERCE BIOTECH
Physicians recommend diclofenac as gold standard raised by health ministry
10 Aug 2018 //
PHARMABIZ
CEPI -Themis Bioscience to Advance Vaccines Against Lassa Fever & MERS
07 Mar 2018 //
BUSINESSWIRE
As killer virus outbreaks hit unprecedented levels, nonprofit hands $37.5M
07 Mar 2018 //
ENDPTS
Novartis`s diclofinac injection flagged by India health ministry panel
04 Jan 2018 //
LIVE MINT
Artemis Biotech Fails EDQM Inspection
11 Aug 2016 //
EDQM
AbbVie orders $30M of Galapagos` IPO, Indivior aces schizophrenia trial, Gilead inks Danish deal
07 May 2015 //
FIERCE BIOTECH
Themis raises €7M, adds GSK vet to board as partnership plans gather pace
06 May 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.